Condition
Kidney Impairment
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 1 (3)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06248567Phase 1CompletedPrimary
Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease
NCT06613763Phase 1CompletedPrimary
A Study of RAY1225 in Participants With Impaired Kidney Function
NCT04308642CompletedPrimary
Study to Evaluate Blood and Urine Kidney Injury Markers to Facilitate Early Detection of Renal Adverse Drug Events in Pediatric Cancer Patients Treated With Nephrotoxic Chemotherapy
NCT06160622Phase 1CompletedPrimary
Pharmacokinetics of Leritrelvir(RAY1216) in Participants With Severe Kidney Disease
Showing all 4 trials